Cargando…

Cross-Neutralization of SARS-CoV-2-Specific Antibodies in Convalescent and Immunized Human Sera against the Bat and Pangolin Coronaviruses

Coronaviruses isolated from bats and pangolins are closely related to SARS-CoV-2, the causative agent of COVID-19. These so-called sarbecoviruses are thought to pose an acute pandemic threat. As SARS-CoV-2 infection and vaccination have become more widespread, it is not known whether neutralizing an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Srisutthisamphan, Kanjana, Saenboonrueng, Janya, Wanitchang, Asawin, Viriyakitkosol, Ratchanont, Jongkaewwattana, Anan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9413129/ https://www.ncbi.nlm.nih.gov/pubmed/36016415 http://dx.doi.org/10.3390/v14081793

Ejemplares similares

Impact of mAb-induced A475V substitution on viral fitness and antibody neutralization of SARS-CoV-2 omicron variants in the presence of monoclonal antibodies and human convalescent sera
por: Viriyakitkosol, Ratchanont, et al.
Publicado: (2023)

Characterization of influenza A virus pseudotyped with the spike protein of porcine epidemic diarrhea virus
por: Wanitchang, Asawin, et al.
Publicado: (2018)

A Single-Cycle Influenza A Virus-Based SARS-CoV-2 Vaccine Elicits Potent Immune Responses in a Mouse Model
por: Koonpaew, Surapong, et al.
Publicado: (2021)

A Single V672F Substitution in the Spike Protein of Field-Isolated PEDV Promotes Cell–Cell Fusion and Replication in VeroE6 Cells
por: Wanitchang, Asawin, et al.
Publicado: (2019)

SARS-CoV-2 Delta (B.1.617.2) variant replicates and induces syncytia formation in human induced pluripotent stem cell-derived macrophages
por: Thaweerattanasinp, Theeradej, et al.
Publicado: (2023)

PEDV ORF3 Independently Regulates IκB Kinase β-Mediated NF-κB and IFN-β Promoter Activities
por: Kaewborisuth, Challika, et al.
Publicado: (2020)

In Vitro and In Vivo Attenuation of Vesicular Stomatitis Virus (VSV) by Phosphoprotein Deletion
por: Wongthida, Phonphimon, et al.
Publicado: (2016)

Interaction Between PEDV and Its Hosts: A Closer Look at the ORF3 Accessory Protein
por: Jantraphakorn, Yuparat, et al.
Publicado: (2021)

Chimeric Virus-like Particle-Based COVID-19 Vaccine Confers Strong Protection against SARS-CoV-2 Viremia in K18-hACE2 Mice
por: Kaewborisuth, Challika, et al.
Publicado: (2022)

A recombinant subunit vaccine candidate produced in plants elicits neutralizing antibodies against SARS-CoV-2 variants in macaques
por: Khorattanakulchai, Narach, et al.
Publicado: (2022)

Functional comparison of SARS-CoV-2 with closely related pangolin and bat coronaviruses
por: Nie, Jianhui, et al.
Publicado: (2021)

Emerging SARS-CoV-2 variants reduce neutralization sensitivity to convalescent sera and monoclonal antibodies
por: Hu, Jie, et al.
Publicado: (2021)

Evidence for SARS-CoV-2 related coronaviruses circulating in bats and pangolins in Southeast Asia
por: Wacharapluesadee, Supaporn, et al.
Publicado: (2021)

Neutralizing antibody activity in convalescent sera from infection in humans with SARS-CoV-2 and variants of concern
por: Dupont, Liane, et al.
Publicado: (2021)

Pseudotyped Bat Coronavirus RaTG13 is efficiently neutralised by convalescent sera from SARS-CoV-2 infected patients
por: Cantoni, Diego, et al.
Publicado: (2022)

Cross-reactive antibodies in convalescent SARS patients' sera against the emerging novel human coronavirus EMC (2012) by both immunofluorescent and neutralizing antibody tests
por: Chan, Kwok-Hung, et al.
Publicado: (2013)

Bat and pangolin coronavirus spike glycoprotein structures provide insights into SARS-CoV-2 evolution
por: Zhang, Shuyuan, et al.
Publicado: (2021)

Sensitivity of SARS-CoV-2 Variants to Neutralization by Convalescent Sera and a VH3-30 Monoclonal Antibody
por: Yue, Shuai, et al.
Publicado: (2021)

SARS-CoV-2 Omicron neutralization by therapeutic antibodies, convalescent sera, and post-mRNA vaccine booster
por: Lusvarghi, Sabrina, et al.
Publicado: (2021)

The Pilot Study of Immunogenicity and Adverse Events of a COVID-19 Vaccine Regimen: Priming with Inactivated Whole SARS-CoV-2 Vaccine (CoronaVac) and Boosting with the Adenoviral Vector (ChAdOx1 nCoV-19) Vaccine
por: Mahasirimongkol, Surakameth, et al.
Publicado: (2022)

Computational Analysis of SARS-CoV-2 and SARS-Like Coronavirus Diversity in Human, Bat and Pangolin Populations
por: Dimonaco, Nicholas J., et al.
Publicado: (2020)

Author Correction: Evidence for SARS-CoV-2 related coronaviruses circulating in bats and pangolins in Southeast Asia
por: Wacharapluesadee, Supaporn, et al.
Publicado: (2021)

NEUTRALIZATION TESTS WITH SERA OF CONVALESCENT OR IMMUNIZED ANIMALS AND THE VIRUSES OF SWINE AND HUMAN INFLUENZA
por: Francis, Thomas, et al.
Publicado: (1936)

The use of SARS-CoV-2-related coronaviruses from bats and pangolins to polarize mutations in SARS-Cov-2
por: Li, Tao, et al.
Publicado: (2020)

Sensitivity of SARS-CoV-2 antibody tests with late convalescent sera
por: Kannenberg, Judith, et al.
Publicado: (2021)

Neutralizing antibodies in convalescent patients
por: Uhl, Lion F. K., et al.
Publicado: (2020)

Assessment of safety and intranasal neutralizing antibodies of HPMC-based human anti-SARS-CoV-2 IgG1 nasal spray in healthy volunteers
por: Imsuwansri, Thanarath, et al.
Publicado: (2023)

Reduced neutralization of SARS-CoV-2 B.1.617 variant by convalescent and vaccinated sera
por: Hu, Jie, et al.
Publicado: (2021)

Neutralization heterogeneity of circulating SARS-CoV-2 variants to sera elicited by a vaccinee or convalescent
por: Zhang, Meng, et al.
Publicado: (2022)

High Heterogeneity of Virus-Neutralizing and RBD-Binding Activities of COVID-19 Convalescent Sera
por: Astakhova, E. A., et al.
Publicado: (2022)

SARS corona virus peptides recognized by antibodies in the sera of convalescent cases
por: Guo, Jian-Ping, et al.
Publicado: (2004)

Convalescent-Phase Sera and Vaccine-Elicited Antibodies Largely Maintain Neutralizing Titer against Global SARS-CoV-2 Variant Spikes
por: Tada, Takuya, et al.
Publicado: (2021)

Comparative analysis of serologic cross-reactivity using convalescent sera from filovirus-experimentally infected fruit bats
por: Schuh, Amy J., et al.
Publicado: (2019)

Bats, pangolins, minks and other animals - villains or victims of SARS-CoV-2?
por: do Vale, Beatriz, et al.
Publicado: (2021)

Strategy To Assess Zoonotic Potential Reveals Low Risk Posed by SARS-Related Coronaviruses from Bat and Pangolin
por: Yang, Yong, et al.
Publicado: (2023)

Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera
por: Supasa, Piyada, et al.
Publicado: (2021)

Comparative genomic signature representations of the emerging COVID-19 coronavirus and other coronaviruses: High identity and possible recombination between Bat and Pangolin coronaviruses
por: Touati, Rabeb, et al.
Publicado: (2020)

SARS-CoV-2 Convalescent Sera Binding and Neutralizing Antibody Concentrations Compared with COVID-19 Vaccine Efficacy Estimates against Symptomatic Infection
por: Schuh, Amy J., et al.
Publicado: (2022)

Pangolins Harbor SARS-CoV-2-Related Coronaviruses
por: Han, Guan-Zhu
Publicado: (2020)

Cross-neutralization of SARS coronavirus-specific antibodies against bat SARS-like coronaviruses
por: Zeng, Lei-Ping, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_bbauuhjuc926rfv0grj940cl48